Cargando…

High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer

Tripartite motif containing 44 (TRIM44) has been reported to be up-regulated in multiple aggressive malignant tumors. However, its expression status and clinical significance in cervical cancer remain unknown. The purpose of this study was to investigate the clinical significance of TRIM44 expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuang, Meng, Fanling, Ding, Jing, Ji, Hongying, Lin, Mu, Zhu, Jiaqi, Ma, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400662/ https://www.ncbi.nlm.nih.gov/pubmed/30792262 http://dx.doi.org/10.1042/BSR20181639

Ejemplares similares

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
por: Liu, Shuang, et al.
Publicado: (2019)

The clinical significance of HPIP and the associated prognosis in cervical cancer
por: Meng, Fanling, et al.
Publicado: (2017)

Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
por: Meng, Fanling, et al.
Publicado: (2022)

Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
por: Ma, Jing, et al.
Publicado: (2019)

TRIM21‑a potential biomarker for the prognosis of thyroid cancer
por: Wu, Zhen, et al.
Publicado: (2022)

Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases
por: Bodaghi, Ali, et al.
Publicado: (2023)

Adjuvant Chemotherapy, a Valuable Alternative Option in Selected Patients with Cervical Cancer
por: Li, Shuang, et al.
Publicado: (2013)

Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
por: Cheng, Li, et al.
Publicado: (2019)

Identification and validation of novel biomarker TRIM8 related to cervical cancer
por: Zhang, Li, et al.
Publicado: (2022)

Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer
por: Goshayeshi, Ladan, et al.
Publicado: (2022)

The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer
por: Sun, Ying, et al.
Publicado: (2022)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022)

Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer
por: Bai, Rui, et al.
Publicado: (2021)

Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury
por: Su, Longxiang, et al.
Publicado: (2015)

Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells
por: Tan, Yuying, et al.
Publicado: (2017)

Elevation of TRIM44 potentiates propagation of gastric cancer stem cells
por: Zhu, Hai, et al.
Publicado: (2021)

TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
por: Lou, Ming, et al.
Publicado: (2020)

Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer
por: Han, Hong-Yan, et al.
Publicado: (2021)

Circulating Soluble Neuropilin-1 in Patients with Early Cervical Cancer and Cervical Intraepithelial Neoplasia Can Be Used as a Valuable Diagnostic Biomarker
por: Yang, Shouhua, et al.
Publicado: (2015)

The ratio of serum Angiopoietin-1 to Angiopoietin-2 in patients with cervical cancer is a valuable diagnostic and prognostic biomarker
por: Yang, Ping, et al.
Publicado: (2017)

Amplification of TRIM44: Pairing a Prognostic Target With Potential Therapeutic Strategy
por: Ong, Chin-Ann Johnny, et al.
Publicado: (2014)

TRIM44 promotes proliferation and metastasis in non-small cell lung cancer via mTOR signaling pathway
por: Xing, Ying, et al.
Publicado: (2016)

Correction: Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer
Publicado: (2021)

Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review
por: Arip, Masita, et al.
Publicado: (2022)

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
por: Peng, Rui, et al.
Publicado: (2018)

TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma
por: Wang, Heng, et al.
Publicado: (2018)

TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma
por: Yamada, Yuta, et al.
Publicado: (2020)

TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: Song, Yurong, et al.
Publicado: (2022)

PBX1 is a valuable prognostic biomarker for patients with breast cancer
por: Ao, Xiang, et al.
Publicado: (2020)

TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway
por: Xiong, Dian, et al.
Publicado: (2018)

YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44
por: Li, Weijian, et al.
Publicado: (2021)

Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44
por: Zou, Peng, et al.
Publicado: (2019)

TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4
por: Wei, Chuan-Yuan, et al.
Publicado: (2019)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer
por: Wei, Bingbing, et al.
Publicado: (2017)

Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway
por: Jiang, Xiao-yu, et al.
Publicado: (2022)

Lymphocyte percentage as a valuable predictor of prognosis in lung cancer
por: Huang, Hong, et al.
Publicado: (2022)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4bs1h9hcu5pfjj35k9mph79kcm